Katacine is a new ligand of CLEC-2 that acts as a platelet agonist

Luis A. Morán, Ying Di, Marcin A. Sowa, Lidia Hermida-Nogueira, María N. Barrachina, Eleyna Martin, Joanne C. Clark, Todd H. Mize, Johannes A. Eble, David Moreira, Alice Y. Pollitt, María I. Loza, Eduardo Domínguez, Steve P. Watson, Ángel García

Research output: Contribution to journalArticlepeer-review

14 Downloads (Pure)

Abstract

Background CLEC-2 is a platelet receptor with an important role in thromboinflammation but a minor role in hemostasis. Two endogenous ligands of CLEC-2 have been identified, the transmembrane protein podoplanin and iron-containing porphyrin hemin, which is formed following hemolysis from red blood cells. Other exogenous ligands such as rhodocytin have contributed to our understanding of the role of CLEC-2.

Objectives To identify novel CLEC-2 small-molecule ligands to aid therapeutic targeting of CLEC-2.

Methods ALPHA screen technology has been used for the development of a high-throughput screening (HTS) assay recapitulating the podoplanin–CLEC-2 interaction. Light transmission aggregometry was used to evaluate platelet aggregation. Immunoprecipitation and western blot were used to evaluate direct phosphorylation of CLEC-2 and downstream protein phosphorylation. Autodock vina software was used to predict the molecular binding site of katacine and mass spectrometry to determine the polymeric nature of the ligand.

Results and Conclusion We developed a CLEC-2–podoplanin interaction assay in a HTS format and screened 5,016 compounds from a European Union-open screen library. We identified katacine, a mixture of polymers of proanthocyanidins, as a novel ligand for CLEC-2 and showed that it induces platelet aggregation and CLEC-2 phosphorylation via Syk and Src kinases. Platelet aggregation induced by katacine is inhibited by the anti-CLEC-2 monoclonal antibody fragment AYP1 F(ab)′2. Katacine is a novel nonprotein ligand of CLEC-2 that could contribute to a better understanding of CLEC-2 activation in human platelets.
Original languageEnglish
Pages (from-to)1361-1368
Number of pages8
JournalThrombosis and Haemostasis
Volume122
Issue number08
Early online date15 Feb 2022
DOIs
Publication statusPublished - Aug 2022

Keywords

  • platelets
  • CLEC-2
  • high-throughput screening
  • small-molecule ligands
  • proanthocyanidin

Fingerprint

Dive into the research topics of 'Katacine is a new ligand of CLEC-2 that acts as a platelet agonist'. Together they form a unique fingerprint.

Cite this